- Fee assured
- Verified this account
This healthcare professional let us know that they are currently:
- Accepting new patients
- Available for:
- Phone consultations
- Face-to-face consultations
- Video consultations
Last updated: 26 May 2020
- General urology
- Urological oncology
I have been cancer lead at Stockport Macclesfield and Tameside hospitals for over 10 years and specialist in the treatment both surgical and non surgical for prostate and bladder cancer. The majority of my major operations are robotic assisted (keyhole) procedures for the treatment of both prostate and bladder cancer. I am currently the only surgeon in greater Manchester offering this type of surgery for bladder cancer and I work in a high volume centre for prostatectomy.
In addition to my cancer interest I also perform surgery and investigations for benign disease, in particular, the surgery to relieve urinary obstruction in men. The BMI Alexandra hospital have recently installed a bipolar set for the endoscopic (through the water pipe) removal of prostates and bladder tumours. This offers a safer alternative to patients undergoing these procedures.
I work in a group of urologists called Manchester Urology and together we cover all the different aspects of urological care and surgery.
Areas of interest
Prostate cancer; bladder cancer; benign conditions of the prostate; pelvic floor pain; the use of MRI scanning in the diagnosis of prostate cancer and raised PSA
- Maria Andrews
- Manor lodge Mill Lane CHEADLE SK8 2NT
- 0161 495 7794
Anaesthetists worked with
- Dr Sengottiyan Chandrasekaran Fee Assured
Current NHS consultant posts held
Examiner for royal college of surgeons
Brough RJ, O’Flynn KJ.
Recurrent pelvic endometriosis and bilateral ureteric obstruction associated with hormone replacement therapy. BMJ 1996, 312: 1221-1222.
Letter of reply: BMJ 1996, 313: 551
Brough RJ, Pidd H, O’Flynn K, Payne SR.
Identification of patients requiring follow up after transurethral prostatectomy - Is there a role for nurse led screening of post-operative outcomes by telephone? B J Urol 1996, 78: 401-404.
Payne SR, Brough RJ, Mellor DE.
Resource implications of outpatient referrals to a general urological service. Ann R Coll Engl 1997, 79: 111-114.
Brough RJ, Lancashire M, Prince J, Rose M, Payne SR and Testa HJ.
The effect of analgesia on ureteric peristalsis and the isotope renogram. Nuc. Med Comm. 1997, 18: 310 - 311
Brough RJ, Fishwick J, O’Flynn KJ and Gough DS.
Bladder washout and stone formation in paediatric enterocystoplasty.
Eur Urol. 1998, 33: 500-502
Brough RJ, Lancashire MJR, Prince JR, Prescott MC, Testa HJ, Payne SR. The effects of Diclofenac (Voltarol) and Pethidine on upper urinary tract drainage of healthy volunteers. Euro J Nuc Med. 1998, 25: 1520-3
Manikandan R, Nathaniel C, Lewis P, Brough RJ, Adeyoju A, Brown SC, Collins GN. Troponin T and N-terminal pro-brain naturetic peptide changes in patients undergoing TURP. J Urol Nov;174(5): 1892-5
Hawary AM, Warburton HE, Brough RJ, Collins GN, Brown SC, O’Reilly PH, Adeyoju AA. The 2 week wait rule for referrals for suspected urological cancers-urgent need for refinement of criteria. Ann R Coll Surg Eng 2008 Sept 90 (6); 517-22.
Anandas CN, Clarke NW, Davidson SE, O’Reilly PH, Logue JP Brough RJ et al.
Early prostate cancer-which treatment do men prefer and why?. BJU int 2011 Jun;107(11): 1762-8
Smolski M, Esler RC, Turo R, Collins GN, Oakley N, Brough R
Bladder neck sparing in radical prostatectomy. Indian J Urol 2013 Oct; 29(4): 338-44
Turo R, Smolski M, Esler R, Kujawa ML, Bromage SJ, Oakley N, Adeyoju A, Brown SC, Brough R, Sinclair A, Collins GN
Diethylstilboestriol for the treatment of prostate cancer: Past present and future. Scand J Urol 2014 Feb; 48(1); 4-14.
Turo R, Smolski M, Kujawa M, Brown SC, Brough R, Collins GN
Acute urinary retention in women due to urethral calculi: A rare case. Can Urol Assoc J. 2014 Jan-Feb;8(1-2) E99-E100
Turo R, Smolski M, Hatimy U, Bromage SJ, Brown SC, Brough R, Collins GN.
A rare case of testicular metastasis of bladder transitional cell carcinoma. Can Urol Assoc J. 2014 Mar-Apr;8(3-4):E181-3
Outcomes (checked and approved by medical professional body)
Please click on this link if you would like to see information about this healthcare professional’s performance compared to their peers, as published by their medical professional body.https://www.baus.org.uk/patients/surgical_outcomes/radical_prostatectomy/default.aspx
in the last national prostate cancer audit our centre had a 2% readmission rate (national average 4%)
and patient suffering urinary symptoms after 2 years following surgery was 5% (national average 10%)
- MB ChB Manchester university 1987
- FRCS (Urol) BAUS 1998
- MD Manchester University 1997
- fellowship in Australia Prince Alfred 1998
Reference number 3175141
Details of entry to specialist register
- FRCS (urol), 1998
Affiliations / memberships
British association of Urological surgeons
European Urological association
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.